The combination therapy with EpCAM/CD3 BsAb and MUC-1/CD3 BsAb elicited antitumor immunity by T-cell adoptive immunotherapy in lung cancer

Ce Wang(Jinan University), Furong Li(Kunming Medical University), Yingjuan Wu(Jinan University), Jingbo Wang(Tang Du Hospital), Shang Chen(Ministry of Natural Resources), Di Wu(Shenzhen Second People's Hospital)
International Journal of Medical Sciences
January 1, 2021
Cited by 8


Related Papers